search
Back to results

Computational Model of SNS (Sacral Nerve Stimulation) Induced Electrical Current Flow Using Tractography Imaging

Primary Purpose

Faecal Incontinence

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
CT scan
Sponsored by
London North West Healthcare NHS Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Faecal Incontinence focused on measuring Sacral Nerve Stimulator;, DTI;, MRI;, Faecal Incontinence;, CT scan;

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients who are psychologically stable and suitable for intervention and able to provide informed consent
  • Patients with symptoms of faecal incontinence for solid or liquid stool
  • Patients who have had successful outcome from temporary SNS
  • Patients who are willing and competent to fill in questionnaires and undergo an extra CT and MRI scan during the study

Exclusion Criteria:

  • Patients who are claustrophobic to undertake MRI scan
  • Patients who had previous devices implanted that may be magnetically, electrically, mechanically activated or affected by MRI scan
  • Pregnant patients
  • Patients who are breastfeeding
  • Patients who are psychologically unstable and unsuitable for intervention and unable to provide informed consent
  • Patients who did not successfully pass the trial of SNS temporary SNS)

Sites / Locations

  • London North West NHS Trust

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Active Comparator

Arm Label

MRI sequences and (DTI)

CT scan

Arm Description

The aim of this study is to obtain finer details of tissues surrounding a lead in the pelvis using a combination of high resolution anatomical MRI sequences and diffusion tensor imaging (DTI). To do so, the patient will undergo a MRI scan (3 Tesla) of the pelvis using sequences including anatomical sequences and diffusion tensor imaging technique for construction of sacral nerve tractography prior to permanent SNS. This will be performed over an hour: first 30 minutes for anatomical sequences and the second 30 minutes for DTI sequencing.

Three to 4 weeks after the procedure the patient will undergo a limited CT scan of the pelvis to visualise the position of the SNS lead. The scan will focus only on the sacrum, implanted lead, and rectum and will not be extended beyond this area. Imaging from this CT will be superimposed to the MRI imaging the patient had pre-operatively, and a computational simulation will be performed.

Outcomes

Primary Outcome Measures

Implanting a lead around a nerve for finer details of tissues surrounding a sacral nerve stimulation lead.
Size and distance of the sacral nerves from the implanted lead measured in millimetres (mm).

Secondary Outcome Measures

Stimulation of the sacral nerve using computational model induced electrical current to establish therapeutic range of SNS
Patient's sensation of stimulation will be measured in amplitude (reported in voltage) shown in the standard remote control during the patient stimulation.

Full Information

First Posted
April 16, 2018
Last Updated
September 17, 2021
Sponsor
London North West Healthcare NHS Trust
Collaborators
Medtronic
search

1. Study Identification

Unique Protocol Identification Number
NCT05049486
Brief Title
Computational Model of SNS (Sacral Nerve Stimulation) Induced Electrical Current Flow Using Tractography Imaging
Official Title
Computational Model of SNS Using Tractography
Study Type
Interventional

2. Study Status

Record Verification Date
April 2018
Overall Recruitment Status
Completed
Study Start Date
October 1, 2017 (Actual)
Primary Completion Date
December 1, 2017 (Actual)
Study Completion Date
March 26, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
London North West Healthcare NHS Trust
Collaborators
Medtronic

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study aims to obtain finer details of tissues surrounding a lead in the pelvis using a combination of high-resolution anatomical MRI sequences and diffusion tensor imaging (DTI). DTI is a non-invasive technique sometimes described as fiber tractography that enables visualization of the pathways and integrity of nerves. In this feasibility study, we plan to use DTI to assess the sacral plexus and its peripheral nerves. A model will be constructed by superimposing SNS lead from a CT scan onto the DTI imaging to map out the electrode position. It is hoped that this study will lead to a better understanding of both therapeutic and adverse stimulation effects and enable patient-specific adjustments of stimulation parameters.
Detailed Description
Patients who have had successful temporary SNS and awaiting permanent SNS will be approached. An assessment will be made to determine whether the patient meets the inclusion/exclusion criteria. Patients will be given a consent form to sign. The investigators will recruit from the outpatient clinic a total of ten patients for this study. A physical examination will be performed as per standard practice. Patients will be asked to fill in questionnaires probing the severity of faecal incontinence symptoms. Included questionnaires are ICIQ-B4, Wexner's and St Mark's. Incontinence score (see appendix). It will also evaluate any existing pain symptoms. The patient will undergo an MRI scan (3 Tesla) of the pelvis using sequences including anatomical sequences and diffusion tensor imaging technique for construction of sacral nerve tractography prior to permanent SNS. This will be performed at Mount Vernon Hospital over an hour: first 30 minutes for anatomical sequences and the second 30 minutes for DTI sequencing. A surgical procedure (implant of SNS) will be performed as per standard practice. Briefly, an antibiotic will be given at induction of anesthesia prior to skin incision. All types of equipment for SNS implantation will be soaked in antibiotic solution (gentamicin 80mg in 500ml of normal saline or equivalent). Under general anesthesia without neuromuscular junction blockade and the patient in prone position, a permanent quadripolar lead (model 3889) will be inserted aiming to observe contraction of the anus and/or toe flexion, which are signs to confirm that the lead is nearby third sacral nerve root. The lead position will be confirmed by an x-ray and the lead will be connected to an implantable neurostimulator which will be placed under the skin but deep enough in the upper outer area of the buttock region. The procedure will be performed according to the manufacturer's manual as per our clinical standard. After the implantation, patients will be given one generic starting program to start the therapy. Three to 4 weeks after the procedure the patient will undergo a limited CT scan of the pelvis to visualise the position of the SNS lead. The scan will focus only on the sacrum, implanted lead, and rectum and will not be extended beyond this area. Imaging from this CT will be superimposed to the MRI imaging the patient had pre-operatively, and a computational simulation will be performed (see details below). After the scan, a clinician will test stimulation settings systematically to find an optimal program. Briefly, as the lead as 4 electrodes, each electrode will be tested, followed by a combination of electrodes. The patient's subjective responses (type and site of sensation, if there is any pain/discomfort site and nature, a degree of pain using a Lickert scale,) will be recorded. The investigators will try and obtain motor response if possible, at the level when patients' anus contracts slightly if this is achievable without causing significant distress and pain to the patients. This is also a routine process and the clinician will note if there is any specific setting that causes adverse pain and identify settings that are comfortable and give stimulation sensation around the anus. The computational model will be done in a computer laboratory and the record will be compared and evaluated for any clinical relevance. The same set of questionnaires used during the baseline evaluation will be repeated at follow-ups, as per routine care.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Faecal Incontinence
Keywords
Sacral Nerve Stimulator;, DTI;, MRI;, Faecal Incontinence;, CT scan;

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
10 (Actual)

8. Arms, Groups, and Interventions

Arm Title
MRI sequences and (DTI)
Arm Type
No Intervention
Arm Description
The aim of this study is to obtain finer details of tissues surrounding a lead in the pelvis using a combination of high resolution anatomical MRI sequences and diffusion tensor imaging (DTI). To do so, the patient will undergo a MRI scan (3 Tesla) of the pelvis using sequences including anatomical sequences and diffusion tensor imaging technique for construction of sacral nerve tractography prior to permanent SNS. This will be performed over an hour: first 30 minutes for anatomical sequences and the second 30 minutes for DTI sequencing.
Arm Title
CT scan
Arm Type
Active Comparator
Arm Description
Three to 4 weeks after the procedure the patient will undergo a limited CT scan of the pelvis to visualise the position of the SNS lead. The scan will focus only on the sacrum, implanted lead, and rectum and will not be extended beyond this area. Imaging from this CT will be superimposed to the MRI imaging the patient had pre-operatively, and a computational simulation will be performed.
Intervention Type
Radiation
Intervention Name(s)
CT scan
Intervention Description
Patients will undergone a pelvic CT scan.
Primary Outcome Measure Information:
Title
Implanting a lead around a nerve for finer details of tissues surrounding a sacral nerve stimulation lead.
Description
Size and distance of the sacral nerves from the implanted lead measured in millimetres (mm).
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Stimulation of the sacral nerve using computational model induced electrical current to establish therapeutic range of SNS
Description
Patient's sensation of stimulation will be measured in amplitude (reported in voltage) shown in the standard remote control during the patient stimulation.
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients who are psychologically stable and suitable for intervention and able to provide informed consent Patients with symptoms of faecal incontinence for solid or liquid stool Patients who have had successful outcome from temporary SNS Patients who are willing and competent to fill in questionnaires and undergo an extra CT and MRI scan during the study Exclusion Criteria: Patients who are claustrophobic to undertake MRI scan Patients who had previous devices implanted that may be magnetically, electrically, mechanically activated or affected by MRI scan Pregnant patients Patients who are breastfeeding Patients who are psychologically unstable and unsuitable for intervention and unable to provide informed consent Patients who did not successfully pass the trial of SNS temporary SNS)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carolynne Vaizey, FRCS
Organizational Affiliation
London North West NHS Trust
Official's Role
Principal Investigator
Facility Information:
Facility Name
London North West NHS Trust
City
Harrow
ZIP/Postal Code
HA1 3UJ
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
There is no plan to make IPD. Reserach results will be shared at the end of the study by local conferences and by peer scientific journals.
Citations:
PubMed Identifier
8416784
Citation
Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum. 1993 Jan;36(1):77-97. doi: 10.1007/BF02050307.
Results Reference
background
PubMed Identifier
9862829
Citation
Vaizey CJ, Carapeti E, Cahill JA, Kamm MA. Prospective comparison of faecal incontinence grading systems. Gut. 1999 Jan;44(1):77-80. doi: 10.1136/gut.44.1.77.
Results Reference
background
PubMed Identifier
23817505
Citation
Maeda Y, Lundby L, Buntzen S, Laurberg S. Outcome of sacral nerve stimulation for fecal incontinence at 5 years. Ann Surg. 2014 Jun;259(6):1126-31. doi: 10.1097/SLA.0b013e31829d3969.
Results Reference
result
PubMed Identifier
21136568
Citation
Maeda Y, Lundby L, Buntzen S, Laurberg S. Suboptimal outcome following sacral nerve stimulation for faecal incontinence. Br J Surg. 2011 Jan;98(1):140-7. doi: 10.1002/bjs.7302. Epub 2010 Oct 27.
Results Reference
result
PubMed Identifier
22705377
Citation
van der Jagt PK, Dik P, Froeling M, Kwee TC, Nievelstein RA, ten Haken B, Leemans A. Architectural configuration and microstructural properties of the sacral plexus: a diffusion tensor MRI and fiber tractography study. Neuroimage. 2012 Sep;62(3):1792-9. doi: 10.1016/j.neuroimage.2012.06.001. Epub 2012 Jun 13.
Results Reference
result
PubMed Identifier
18008106
Citation
Cotterill N, Norton C, Avery KN, Abrams P, Donovan JL. A patient-centered approach to developing a comprehensive symptom and quality of life assessment of anal incontinence. Dis Colon Rectum. 2008 Jan;51(1):82-7. doi: 10.1007/s10350-007-9069-3. Epub 2007 Nov 15.
Results Reference
result

Learn more about this trial

Computational Model of SNS (Sacral Nerve Stimulation) Induced Electrical Current Flow Using Tractography Imaging

We'll reach out to this number within 24 hrs